- Home
- CPSH vs VTVT Comparison
CPSH vs VTVT Comparison
Compare CPSH & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPSH | VTVT |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.4M | 54.4M |
| IPO Year | 1987 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CPSH | VTVT |
|---|---|---|
| Price | $3.35 | $26.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 139.0K | 12.9K |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,321,555.00 | $17,000.00 |
| Revenue This Year | $55.87 | N/A |
| Revenue Next Year | $19.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 38.22 | N/A |
| 52 Week Low | $1.40 | $13.15 |
| 52 Week High | $4.89 | $33.16 |
Technical Indicators
Market Signals| Indicator | CPSH | VTVT |
|---|---|---|
| Relative Strength Index (RSI) | 46.12 | 52.96 |
| Support Level | $3.15 | $22.92 |
| Resistance Level | $3.44 | $32.53 |
| Average True Range (ATR) | 0.19 | 1.72 |
| MACD | 0.02 | -0.57 |
| Stochastic Oscillator | 47.28 | 43.27 |
Price Performance
Historical ComparisonAbout CPSH CPS Technologies Corp.
CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.